<PAGE>
----------------------------
OMB APPROVAL
----------------------------
OMB Number:......3235-0145
----------------------------
Expires: October 31, 1997
Estimated average burden
hours per response....14.90
----------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)
-------
GIBRALTAR PACKAGING GROUP, INC.
- --------------------------------------------------------------------------------
Common Stock, $.01 par value
- --------------------------------------------------------------------------------
374758-100
-----------------------------------------------
Harvey M. Eisenberg, Esq.
O'Sullivan, Graev & Karabell, LLP
30 Rockefeller Plaza
41st Floor
New York, New York 10112
(212) 408-2400
- --------------------------------------------------------------------------------
January 1, 1998
-----------------------------------------------
Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4),
check the following box / /
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP No. 374758-100 Page 2 of 9 Pages
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Chase Venture Capital Association, L.P. (f/k/a Chemical Venture Capital
Associates, A California Limited Partnership) 13-337-6808
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
SC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e).
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 274,739
SHARES BENEFICIALLY -------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING -------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 274,739
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
274,739
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
/ /
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11
5.5%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- --------------------------------------------------------------------------------
2 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
Preliminary Note
- ----------------
All information set forth herein has been adjusted to reflect a change in the
name and address of the reporting person.
Item 2. Identity and Background.
- -----------------------------------
This statement is being filed by Chase Venture Capital Associates, L.P. (f/k/a
Chemical Venture Capital Associates, A California Limited Partnership)
(hereinafter referred to as "CVCA"), whose principal business office is located
at 380 Madison Avenue, 12th Floor, New York, New York 10017. The general partner
of CVCA is Chase Capital Partners (f/k/a Chemical Venture Partners), a New York
general partnership ("CCP"), whose principal business office is located at the
same address as CVCA.
Set forth below are the names of each general partner of CCP who is a natural
person. Each such general partner is a U.S. citizen, whose principal occupation
is general partner of CCP and whose principal business office address (except
for Mr. Soghikian) is c/o Chase Capital Partners, 380 Madison Avenue, 12th
Floor, New York, New York 10017.
John R. Baron
Mitchell J. Blutt, M.D.
Arnold L. Chavkin
Michael R. Hannon
Donald J. Hofmann
Stephen P. Murray
John M. B. O'Connor
Brian J. Richmand
Shahan D. Soghikian
Jeffrey C. Walker
Damion E. Wicker, M.D.
Mr. Soghikian's principal business office address is c/o Chase Capital Partners,
125 London Wall, London EC2Y5AJ, England.
Jeffrey C. Walker is the managing general partner of CCP. The remaining general
partners of CCP are Chase Capital Corporation (f/k/a Chemical Capital
Corporation), a New York corporation ("Chase Capital"), CCP Principals, L.P.
(f/k/a CVP Principals, L.P.), a Delaware limited partnership ("Principals") and
CCP European Principals, L.P., a Delaware limited partnership ("European
Principals"), each of whose principal business office is located at the same
address as CVCA. Chase Capital is a wholly owned subsidiary of The Chase
Manhattan Corporation (f/k/a Chemical Banking Corporation), a Delaware
corporation. The general partner of each of Principals and European Principals
is Chase Capital. Set forth in Schedule A hereto and incorporated herein by
reference are the names, business addresses, principal occupations of each
executive officer of Chase Capital, each of whom is a U.S. citizen.
3 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- ------ ------------
- --------------------------------------------------------------------------------
The Chase Manhattan Corporation ("Chase") is a Delaware corporation engaged
(primarily through subsidiaries) in the commercial banking business with its
principal office located at 270 Park Avenue, New York, New York 10017. Set forth
in Schedule B hereto and incorporated herein by reference are the names,
business addresses, principal occupations and employments of each executive
officer and director of Chase, each of whom is a U.S. citizen.
To CVCA's knowledge, the response to Items 2(d) and (e) of Schedule 13D is
negative with respect to CVCA and all persons regarding whom information is
required hereunder by virtue of CVCA's response to Item 2.
Insofar as the requirements of Items 3-6 inclusive of this Schedule 13D
Statement require that, in addition to CVCA, the information called for therein
should be given with respect to each of the persons listed in this Item 2,
including CCP, CCP's individual general partners, Chase Capital, Chase Capital's
executive officers and directors, Principals, and Principals' controlling
partner, European Principals and European Principals' controlling partner, Chase
and Chase's executive officers and directors, the information provided in Items
3-6 with respect to CVCA should also be considered fully responsive with respect
to the aforementioned persons who have no separate interests in the Issuer's
Common Stock which is required to be reported thereunder. Although the
definition of "beneficial ownership" in Rule 13d-3 under the Securities and
Exchange Act of 1934, as amended (the "Exchange Act"), might also be deemed to
constitute these persons beneficial owners of the Issuer's Common Stock acquired
by CVCA, neither the filing of this statement nor any of its contents shall be
deemed an admission that any of such persons is a beneficial owner of the
Issuer's Common Stock acquired by CVCA or a member of a group together with CVCA
either for the purpose of Schedule 13D of the Exchange Act or for any other
purpose with respect to the Issuer's Common Stock.
Item 7. Material to be Filed as Exhibits.
- -------------------------------------------
*1.Agreement and Plan of Reorganization, dated as of April 28,
1993, among the Issuer, Acquisition, Holdings, Niemand, CVCA and the Other
Shareholders (without Exhibits or Appendices).
*2.Letter Agreement, dated April 28, 1993, between the Issuer and
CVCA.
*3.Registration Rights Agreement, dated as of April 28, 1993,
among the Issuer, CVCA and the Other Shareholders.
*4.Agreement Among Shareholders, dated as of April 28, 1993, among
CVCA and the Other Shareholders.
SCHEDULE A
- ----------
Item 2 information for executive officers and directors of Chase
Capital.
SCHEDULE B
- ----------
Item 2 information for executive officers and directors of Chase.
- --------------------------------------------------------------------------------
* Filed Previously
4 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 13, 1998 CHASE VENTURE CAPITAL ASSOCIATES, L.P.
By: CHASE CAPITAL PARTNERS,
its General Partner
By:/s/ Jeffrey C. Walker
---------------------
Name: Jeffrey C. Walker
Title: Managing General Partner
5 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
SCHEDULE A
CHASE CAPITAL CORPORATION
Executive Officers
Name
----
Chief Executive Officer William B. Harrison, Jr.*
President Jeffrey C. Walker**
Executive Vice President Mitchell J. Blutt, M.D.**
Vice President & Secretary Gregory Meridith*
Vice President George E. Kelts**
Assistant Secretary Robert C. Carroll*
Directors
William B. Harrison, Jr.*
Jeffrey C. Walker**
- --------
* Principal occupation is employee and/or officer of Chase. Business address
is c/o The Chase Manhattan Corporation, 270 Park Avenue, New York, New York
10017.
** Principal occupation is employee of Chase and/or general partner of Chase
Capital Partners. Business address is c/o CCP, 380 Madison Avenue, 12th
Floor, New York, NY 10017.
6 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
SCHEDULE B
THE CHASE MANHATTAN CORPORATION
Executive Officers*
Walter V. Shipley, Chairman
Thomas G. Labrecque, President
William B. Harrison, Jr., Vice Chairman of the Board
Donald L. Boudreau, Senior Executive Vice President
Marc Shapiro, Senior Executive Vice President
Joseph G. Sponholz, Senior Executive Vice President
Directors**
---------
Principal Occupation or Employment;
Name Business or Residence Address
---- -----------------------------
Hans W. Becherer Chairman of the Board
Chief Executive Officer
Deere & Company
8601 John Deere Road
Moline, IL 61265
Frank A. Bennack, Jr. President and Chief Executive Officer
The Hearst Corporation
959 Eighth Avenue
New York, NY 10019
Susan V. Berresford President
The Ford Foundation
320 East 43rd Street
New York, NY 10017
- --------------------------------------------------------------------------------
* Principal occupation is executive officer and/or employee of The Chase
Manhattan Bank. Business address is c/o The Chase Manhattan Bank, 270 Park
Avenue, New York, New York 10017. Each executive officer of Chase is a U.S.
citizen.
** Each of the persons named below is a citizen of the United States of
America.
7 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
Principal Occupation or Employment;
Name Business or Residence Address
---- -----------------------------
M. Anthony Burns Chairman, President and CEO
Ryder System, Inc.
3600 N.W. S2nd Avenue
Miami, FL 33166
H. Laurance Fuller Chairman of the Board and
Chief Executive Officer
Amoco Corporation
200 East Randolph Drive
Chicago, IL 60601
Melvin R. Goodes Chairman of the Board and Chief Executive Officer
Warner-Lambert Company
201 Tabor Road
Morris Plains, NJ 07950
William H. Gray, III President and Chief Executive Officer
The College Fund/UNCF
8260 Willow Oaks Corporate Drive
P.O. Box 10444
Fairfax, VA 22031
George V. Grune Chairman of the Board and Chief Executive Officer
The Reader's Digest Association, Inc.
Chairman of the Board
The DeWitt Wallace-Reader's Digest Fund
Lila Wallace-Reader's Digest Fund
Reader's Digest Road
Pleasantville, NY 10570
William B. Harrison, Jr. Vice Chairman of the Board
The Chase Manhattan Corporation
270 Park Avenue, 8th Floor
New York, NY 10017-2070
Harold S. Hook Retired Chairman of the Board
American General Corporation
2929 Allen Parkway
Houston, TX 77019
Helene L. Kaplan Of Counsel
Skadden, Arps, Slate, Meagher & Flom
919 Third Avenue - Room 29-72
New York, NY 10022
8 of 9
<PAGE>
SCHEDULE 13D
------------
Issuer: Gibraltar Packaging Group, Inc. CUSIP Number: 374758-100
- --------------------------------------------------------------------------------
Principal Occupation or Employment;
Name Business or Residence Address
---- -----------------------------
Thomas G. Labrecque President
The Chase Manhattan Corporation
270 Park Avenue, 8th Floor
New York, NY 10017-2070
Henry B. Schacht Retired Chairman of the Board and
Chief Executive Officer
Lucent Technologies, Inc.
600 Mountain Avenue - Room 6A511 Murray
Hill, NJ 07974
Walter V. Shipley Chairman of the Board
The Chase Manhattan Corporation
270 Park Avenue, 8th Floor
New York, NY 10017-2070
Andrew C. Sigler Retired Chairman of the Board
and Chief Executive Officer
Champion International Corporation
1 Champion Plaza
Stamford, CT 06921
John R. Stafford Chairman, President and Chief
Executive Officer
American Home Products Corporation
Five Giralda Farms
Madison, NJ 07940
Marina v.N. Whitman Professor of Business Administration
and Public Policy
The University of Michigan
School of Public Policy
411 Lorch Hall, 611 Tappan Street
Ann Arbor, MI 48109-1220
9 of 9
